Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kindler appointed Pfizer chairman

Executive Summary

Pfizer CEO Jeffrey Kindler replaces Hank McKinnell as chairman of the firm's board of directors, effective Dec. 19. The appointment is a vote of confidence in Kindler as the company looks to regain traction following the termination of development of its headline pipeline candidate torcetrapib/atorvastatin (1"The Pink Sheet" Dec. 11, 2006, p. 3). McKinnell, who resigned from the chief executive post in July, was slated to give up the chairman position in February 2007 (2"The Pink Sheet" Aug. 7, 2006, p. 3). Pfizer says McKinnell will step down from the board when he leaves the company in February...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS047872

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel